+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biosimilars And Biosuperiors Market Research Reports

From
From
From
From
From
From
US Biosimilars Market, Dosage, Price & Clinical Pipeline Outlook 2025 - Product Thumbnail Image

US Biosimilars Market, Dosage, Price & Clinical Pipeline Outlook 2025

  • Report
  • April 2019
  • 300 Pages
  • United States
From
US Biosimilar Insulin Market Opportunity & Clinical Trials Insight 2026 - Product Thumbnail Image

US Biosimilar Insulin Market Opportunity & Clinical Trials Insight 2026

  • Report
  • August 2021
  • 50 Pages
  • United States
From
From
From
From
Global Biosimilars Market 2020-2025 - Product Thumbnail Image

Global Biosimilars Market 2020-2025

  • Report
  • May 2021
  • 358 Pages
  • Global
From
Biosimilars and Follow-On Biologics Market Report 2023-2033 - Product Thumbnail Image

Biosimilars and Follow-On Biologics Market Report 2023-2033

  • Report
  • December 2022
  • 337 Pages
  • Global
From
Biosimilar Monoclonal Antibodies Market Report 2022-2032 - Product Thumbnail Image

Biosimilar Monoclonal Antibodies Market Report 2022-2032

  • Report
  • July 2022
  • 461 Pages
  • Global
From
From
Biosimilars Market Global Report 2020-30 - Product Thumbnail Image

Biosimilars Market Global Report 2020-30

  • Report
  • April 2020
  • Global
From
From
From
From
Loading Indicator

The Biosimilars and Biosuperiors market is a rapidly growing sector of the pharmaceutical industry. Biosimilars are biologic drugs that are highly similar to an existing biologic drug, while biosuperiors are biologic drugs that are more effective than an existing biologic drug. Biosimilars and biosuperiors are used to treat a variety of conditions, including cancer, autoimmune diseases, and inflammatory diseases. Biosimilars and biosuperiors are developed using advanced biotechnology techniques, such as recombinant DNA technology and monoclonal antibody technology. These drugs are designed to be more cost-effective than their original counterparts, while still providing the same therapeutic benefits. The Biosimilars and Biosuperiors market is expected to continue to grow in the coming years, as more biologic drugs are developed and approved for use. Companies in this market include Amgen, Pfizer, Merck, and Novartis. Show Less Read more